| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| INBX | Inhibrx Biosciences, Inc. | Mark Lappe | Chief Executive Officer | Sep 12, 2024 | Buy | $15.05 | 26,963 | 405,793 | 692,511 | Sep 16, 2024, 05:12 PM | |
| INBX | Inhibrx Biosciences, Inc. | Mark Lappe | Chief Executive Officer | Sep 16, 2024 | Buy | $17.13 | 13,037 | 223,324 | 705,548 | Sep 16, 2024, 05:12 PM | |
| INBX | Inhibrx Biosciences, Inc. | Mark Lappe | Chief Executive Officer | Sep 10, 2024 | Buy | $15.19 | 8,500 | 129,115 | 665,548 | Sep 10, 2024, 05:00 PM | |
| INBX | Inhibrx Biosciences, Inc. | Mark Lappe | Chief Executive Officer | Sep 06, 2024 | Buy | $15.29 | 26,000 | 397,540 | 647,548 | Sep 10, 2024, 05:00 PM | |
| INBX | Inhibrx Biosciences, Inc. | Mark Lappe | Chief Executive Officer | Sep 09, 2024 | Buy | $15.21 | 9,500 | 144,495 | 657,048 | Sep 10, 2024, 05:00 PM | |
| INBX | Inhibrx Biosciences, Inc. | Mark Lappe | Chief Executive Officer | Aug 29, 2024 | Buy | $14.03 | 10,000 | 140,300 | 135,000 | Sep 03, 2024, 05:31 PM | |
| INBX | Inhibrx Biosciences, Inc. | Mark Lappe | Chief Executive Officer | Aug 30, 2024 | Buy | $14.02 | 10,000 | 140,200 | 145,000 | Sep 03, 2024, 05:31 PM | |
| INBX | Inhibrx Biosciences, Inc. | Mark Lappe | Chief Executive Officer | Sep 03, 2024 | Buy | $15.81 | 20,000 | 316,263 | 165,000 | Sep 03, 2024, 05:31 PM | |
| INBX | Inhibrx Biosciences, Inc. | Mark Lappe | Chief Executive Officer | Aug 20, 2024 | Buy | $12.97 | 27,055 | 350,903 | 41,920 | Aug 22, 2024, 04:29 PM | |
| INBX | Inhibrx Biosciences, Inc. | Mark Lappe | Chief Executive Officer | Aug 21, 2024 | Buy | $12.93 | 12,945 | 167,379 | 54,865 | Aug 22, 2024, 04:29 PM |